Elevate Uranium Secures AU$10 million for Growth Strategy

Elevate Uranium Ltd (ASX: EL8) has successfully garnered AU$10 million through a Placement at AU$0.42 per share, with strong backing from domestic and offshore institutional investors. This funding strengthens Elevate Uranium's balance sheet to approximately AU$17.1 million, positioning the company for an accelerated growth strategy across its Namibian and Australian uranium portfolio. The placement introduces new institutional investors to the share register and offers existing shareholders one free attaching unlisted option for every two shares subscribed.

Managing Director Murray Hill expresses satisfaction with the robust demand, emphasizing the endorsement of Elevate's strategy. The funds will facilitate resource drilling, exploration, technical studies, and potential acquisitions, reinforcing Elevate Uranium's commitment to advancing flagship projects in Namibia and Australia.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com